Shiraj Sen, Aram F. Hezel, Anup Kasi, Nehal J. Lakhani, Alexander I. Spira, Rajwanth Veluswamy, Chenming Xu, Hisaki Fujii, Stanley Gill, Ho-Jin Lee, William Bennion McKean. "Trial in progress: Phase 1 study of the selective protein degrader ASP4396 in patients with locally advanced or metastatic solid tumors with
                    <i>KRAS G12D</i>
                    mutations.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3178